Regulation has always struggled to keep pace with technology. Here are five of the biggest clashes between lawmen and innovators

Imperial, Cambridge and UCL partner up with industry leaders AstraZeneca, GlaxoSmithKline and Johnson & Johnson to advance new treatments

Pfizer, the US’s biggest pharmaceutical company, has its sights set on another huge takeover

Seen as a major breakthrough in cancer treatment, immuno-oncology could be the hope the world has waited for

The New Economy speaks to Dr John Ashton, President of the UK Faculty of Public Health, to ask whether the pharmaceutical industry needs to invest more in curing diseases seen to be less profitable

US pharma giant ups stakes in bid for UK firm; AstraZeneca board rejects offer, while politicians raise concerns over potential job losses

Part 2 of 2: Having overcome patent expirations, and accusations of corruption in China, what does the future hold for pharmaceutical giant GlaxoSmithKline Pharmaceutical? Rita Lobo explores…

The New Economy interviews Dimitri Dimitriou, CEO of Immupharma, on how its drug Lupuzor has been cleared for fast track approval

The New Economy interviews Gordon McCauley, CEO and President of Allon Therapeutics, on a treatment for neuro-degenerative diseases